News
Meet the Wyoming company that could halt Parkinson’s disease – Nitrome Biosciences
October 25, 2018 /
Nitrome Biosciences is developing drugs against a new class of enzymes, initially targeting Parkinson’s disease. When successful, we will have found and characterized a new class of enzymes and will have a proprietary development path for disease-modifying drugs for multiple aging-dependent diseases. We are starting with Parkinson’s disease but this may be extended to include other neurodegenerative diseases, heart disease and cancer.
NITROME BIOSCIENCES, INC
435 Henley Rd
P.O. Box 4971
Jackson, WY 83001
USA
MATR Supporters (view all)
Posted in: Wyoming Business
Sorry, we couldn't find any posts. Please try a different search.